Literature DB >> 35729353

Is adjacent lobe invasion an T category upgrade factor for resected non-small cell lung cancer ≤ 5 cm?

Jing-Sheng Cai1, Qian-Yi Lin2, Xiao-Meng Dou3,4.   

Abstract

PURPOSE: Controversy exists with regard to the T category of non-small cell lung cancer (NSCLC) with adjacent lobe invasion (ALI), and dispute arises on assigning this subset into T2 or T3 category. We evaluated the effect of ALI on the survival of resected NSCLC ≤ 5 cm, with purpose of determining the most appropriate T category for this population.
METHODS: The entire cohort was divided into three subgroups (ALI group, T2 group and T3 group). Kaplan-Meier with log-rank method was carried out to compare overall survival (OS) differences. Propensity score matching (PSM) was performed to minimize bias.
RESULTS: A total of 12,564 eligible NSCLC cases (ALI group: 114 cases; T2 group: 10,046 cases; T3 group: 2404 cases) were included in this study. The incidence of ALI was about 0.9%. Before PSM, survival analyses demonstrated that no significant OS differences were observed between ALI group and T2 group, and between ALI group and T3 group, neither in the entire cohort analysis nor in the subgroup analysis. After PSM, there were 102 pairs and 98 pairs in the ALI and T2 matching group and ALI and T3 matching group, respectively. In the matched cohorts, survival curves showed that the OS of ALI group was comparable to that of T2 group (P = 0.950), but superior to that of T3 group (P = 0.012).
CONCLUSIONS: The current study proposed that NSCLC with ALI ≤ 5 cm should be still categorized as T2 category, which could improve staging accuracy.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Adjacent lobe invasion; Non-small cell lung cancer; Survival; T category

Year:  2022        PMID: 35729353     DOI: 10.1007/s00432-022-04102-1

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  6 in total

1.  The clinical outcome of non-small cell lung cancer patients with adjacent lobe invasion: the optimal classification according to the status of the interlobar pleura at the invasion point.

Authors:  Yoichi Ohtaki; Tomoyuki Hishida; Junji Yoshida; Genichiro Ishii; Akikazu Kawase; Keiju Aokage; Mitsuyo Nishimura; Kanji Nagai
Journal:  Eur J Cardiothorac Surg       Date:  2012-05-16       Impact factor: 4.191

2.  Surgical results and staging of non-small cell lung cancer with interlobar pleural invasion.

Authors:  Ryu Kanzaki; Naoki Ikeda; Eiji Okura; Naoto Kitahara; Yasushi Shintani; Akira Okimura; Kunimitsu Kawahara; Mitsunori Ohta
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-03-14

3.  Lung cancer invading the fissure to the adjacent lobe: more a question of spreading mode than a staging problem.

Authors:  Marc Riquet; Pascal Berna; Alex Arame; Pierre Mordant; Joao Carlos Das Neves Pereira; Christophe Foucault; Antoine Dujon; Françoise Le Pimpec Barthes
Journal:  Eur J Cardiothorac Surg       Date:  2011-12-20       Impact factor: 4.191

4.  Invasion beyond interlobar pleura in non-small cell lung cancer.

Authors:  H Miura; O Taira; O Uchida; H Kato
Journal:  Chest       Date:  1998-11       Impact factor: 9.410

5.  Peripheral direct adjacent lobe invasion non-small cell lung cancer has a similar survival to that of parietal pleural invasion T3 disease.

Authors:  Hao-Xian Yang; Xue Hou; Peng Lin; Hong Yang; Can-Guang Zeng; Tie-Hua Rong; Jian-Hua Fu
Journal:  J Thorac Oncol       Date:  2009-11       Impact factor: 15.609

6.  The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer.

Authors:  Ramón Rami-Porta; David Ball; John Crowley; Dorothy J Giroux; James Jett; William D Travis; Masahiro Tsuboi; Eric Vallières; Peter Goldstraw
Journal:  J Thorac Oncol       Date:  2007-07       Impact factor: 15.609

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.